E.E. Geduld’s DexCom DXCM Stock Holding History

E.E. Geduld’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-20,000	Closed	-$400K	–	227
2015 Q2	$400K	Sell	20,000 -20,000	-50%	-$351K	0.25%	85
2015 Q1	$623K	Hold	40,000	–	–	0.42%	49
2014 Q4	$551K	Hold	40,000	–	–	0.3%	54
2014 Q3	$400K	Hold	40,000	–	–	0.28%	85
2014 Q2	$397K	Sell	40,000 -60,000	-60%	-$532K	0.25%	101
2014 Q1	$1.03M	Hold	100,000	–	–	0.56%	33
2013 Q4	$885K	Hold	100,000	–	–	0.43%	42
2013 Q3	$706K	Buy	100,000 +20,000	+25%	+$127K	0.43%	53
2013 Q2	$449K	Buy	+80,000	New	+$383K	0.32%	90

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

E.E. Geduld's DXCM Position: Q3 2015 in Review

E.E. Geduld sold out of DexCom (DXCM) in Q3 2015, closing a stake of 20,000 shares — an estimated $400K sold.

E.E. Geduld first reported a position in DXCM in Q2 2013 and held it in 9 quarters. The position peaked at $1.03M in Q1 2014. 282 funds tracked by Wall St. Rank hold DXCM as of Q3 2015.

E.E. Geduld reported no remaining DexCom position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 20,000 DexCom shares in Q3 2015, an estimated $400K.
E.E. Geduld first reported a position in DexCom in Q2 2013 and held it in 9 quarters.
E.E. Geduld's DexCom position peaked at $1.03M in Q1 2014.
282 funds tracked by Wall St. Rank held DexCom as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.